Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Phase Ib/IIa Clinical Study of ACC017 Tablets
Phase 1
Recruiting
- Conditions
- Infection, Human Immunodeficiency Virus
- Interventions
- Drug: ACC017+FTC/TAFDrug: Placebo
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Jiangsu Aidea Pharmaceutical Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT06719310
- Locations
- 🇨🇳
Beijing Ditan Hospital, Capital Medical University, Beijing, China
Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants
Phase 1
Recruiting
- Conditions
- Healthy Adult Participants
- Interventions
- Drug: ACC017 tablets
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Jiangsu Aidea Pharmaceutical Co., Ltd
- Target Recruit Count
- 52
- Registration Number
- NCT06278389
- Locations
- 🇨🇳
Beijing Ditan Hospital Capital Medical University, Beijing, China
News
No news found